ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,970.84
-1.11%
US Tech 100
20,897.20
-1.35%
Dow Jones
42,992.21
-0.77%
Brent Oil
73.835
0.29%
Bitcoin
93,524.89
0.01%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Mangoceuticals Inc (MGRX)

  7. Mangoceuticals Inc (MGRX) News

MGRX

Mangoceuticals (MGRX)

Mangoceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MGRX
DateTimeSourceHeadlineSymbolCompany
12/26/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGRXMangoceuticals Inc
12/19/20245:33PMGlobeNewswire Inc.Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations PatentNASDAQ:MGRXMangoceuticals Inc
12/19/20245:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGRXMangoceuticals Inc
12/06/20245:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGRXMangoceuticals Inc
12/04/20247:00AMGlobeNewswire Inc.Mangoceuticals, Inc. Initiates Investigation into Potential Stock Manipulation Scheme Following Recent Reverse Stock SplitNASDAQ:MGRXMangoceuticals Inc
11/14/20244:16PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MGRXMangoceuticals Inc
11/12/20245:04PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGRXMangoceuticals Inc
10/31/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGRXMangoceuticals Inc
10/31/20248:00AMGlobeNewswire Inc.Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:MGRXMangoceuticals Inc
10/25/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGRXMangoceuticals Inc
10/22/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGRXMangoceuticals Inc
10/22/20248:00AMGlobeNewswire Inc.MangoRx Announces Formation of Strategy and Alternatives CommitteeNASDAQ:MGRXMangoceuticals Inc
10/21/20245:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGRXMangoceuticals Inc
10/21/20245:10PMGlobeNewswire Inc.MangoRx Responds to and Refutes Recent Claims Made by Eli LillyNASDAQ:MGRXMangoceuticals Inc
10/11/20245:15PMGlobeNewswire Inc.MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLANNASDAQ:MGRXMangoceuticals Inc
10/03/20248:30AMGlobeNewswire Inc.MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss SolutionsNASDAQ:MGRXMangoceuticals Inc
10/01/20241:05PMAllPennyStocks.comHealthcare Shares Rise Following Product Availability AnnouncementNASDAQ:MGRXMangoceuticals Inc
10/01/20247:30AMGlobeNewswire Inc.MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss TreatmentNASDAQ:MGRXMangoceuticals Inc
08/15/20249:25AMGlobeNewswire Inc.MangoRx Reports 1,685% Increase in Shareholders’ Equity From December 31, 2023, to $13.8MM, and 56% Increase in Year-Over-Year Revenue for First Half of 2024NASDAQ:MGRXMangoceuticals Inc
08/13/20244:00PMGlobeNewswire Inc.MangoRx Receives Certificate of Grant in India for its Respiratory Illness and Preventive Care Technology PatentNASDAQ:MGRXMangoceuticals Inc
08/09/20248:15AMGlobeNewswire Inc.MangoRx Completes Migration to DEA-Approved Telemedicine Platform, Accelerating Timeline of Oral Dissolvable GLP-1 Weight Loss Treatments Featuring Semaglutide and TirzepatideNASDAQ:MGRXMangoceuticals Inc
07/24/20248:15AMGlobeNewswire Inc.MangoRx Initiates Efficacy Studies on its Patented Respiratory Illness Prevention TechnologyNASDAQ:MGRXMangoceuticals Inc
07/18/20244:05PMGlobeNewswire Inc.Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-AccessNASDAQ:MGRXMangoceuticals Inc
07/16/20248:20AMGlobeNewswire Inc.MangoRx Secures DEA Approval for Proprietary HIPAA-Compliant Operating System via SurescriptsNASDAQ:MGRXMangoceuticals Inc
07/12/20241:30PMGlobeNewswire Inc.MangoRx Appoints Dr. Douglas Christianson, N.D. as Director of the Medical Research and Product Innovation DepartmentNASDAQ:MGRXMangoceuticals Inc
07/11/20248:15AMGlobeNewswire Inc.MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging MarketsNASDAQ:MGRXMangoceuticals Inc
06/18/20242:57PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MGRXMangoceuticals Inc
06/10/20241:28PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MGRXMangoceuticals Inc
06/06/20248:30AMGlobeNewswire Inc.MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care TechnologyNASDAQ:MGRXMangoceuticals Inc
06/05/20245:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGRXMangoceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:MGRX

Your Recent History

USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
AABB
Asia Broadband (PK)
USOTC
GDVM
Global Developments (PK)
USOTC
HIRU
Hiru (PK)
COIN
BTCUSD
Bitcoin
USOTC
BIEL
Bioelectronics (PK)
COIN
XRPUSD
Ripple
NASDAQ
LWLG
Lightwave Logic
NASDAQ
AMRN
Amarin
USOTC
NWBO
Northwest Biotherapeutics (QB)
NASDAQ
COOP
Mr Cooper
USOTC
FNMA
Fannie Mae (QB)
USOTC
RDAR
Raadr (PK)
USOTC
RNVA
Rennova Health (CE)
USOTC
HMBL
HUMBL (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads